FDA Warns of Rare Vision Loss Risk Linked to Ozempic, Wegovy and Other GLP-1 Drugs
The FDA is strengthening safety warnings for popular diabetes and weight-loss medications following findings of a slightly increased risk of a rare eye condition, while experts urge patients not to stop treatment without medical guidance
Yuval Aviv
10.11.26 | 14:10